siRNA therapy lowers triglycerides in clients with rare ailment

.STUDY FEATURE.19 September 2024.

Plozasiran decreased triglyceride amounts through 80% and decreased the danger of pancreatitis in patients with constant chylomicronemia, along with or without a hereditary prognosis.